Suppr超能文献

核激素受体介导的基因抑制

Gene repression by nuclear hormone receptors.

作者信息

Moehren Udo, Eckey Maren, Baniahmad Aria

机构信息

Genetic Institute, Justus-Liebig-University, 35392 Giessen, Germany.

出版信息

Essays Biochem. 2004;40:89-104. doi: 10.1042/bse0400089.

Abstract

Repression by nuclear hormone receptors (NHRs) plays an important role in development, immune response and cellular function. We review mechanisms of how NHRs act as repressors of gene transcription either by direct contact with basal transcription factors or through recruitment of cofactors and enzymic activities that modulate chromatin accessibility. We describe also the role and biochemical mechanism of the cognate hormone that switches a NHR from a transcriptional silencer into an activator. This includes data from crystal structure, functional receptor domain analyses and the role of co-repressors in chromatin modification and remodelling. Furthermore, the comparison of negative response elements with classical response elements unravels the role of co-repressors in this context. We also describe the inhibition of the nuclear factor kappaB and Jun/Fos pathway by NHRs, as well as the molecular mechanism of anti-hormone therapies. Anti-hormones are commonly used in breast and prostate cancer therapy to inhibit cancer proliferation through repression of the oestrogen or androgen receptor, respectively. Here we provide a comprehensive overview of the various mechanism of NHR repression.

摘要

核激素受体(NHRs)介导的基因抑制在发育、免疫反应和细胞功能中发挥着重要作用。我们综述了NHRs作为基因转录抑制因子的作用机制,这些机制包括通过与基础转录因子直接接触,或通过募集调节染色质可及性的辅因子和酶活性来实现。我们还描述了同源激素的作用及生化机制,该激素可将NHR从转录沉默因子转变为激活因子。这包括来自晶体结构、功能性受体结构域分析的数据,以及共抑制因子在染色质修饰和重塑中的作用。此外,对负反应元件与经典反应元件的比较揭示了共抑制因子在此背景下的作用。我们还描述了NHRs对核因子κB和Jun/Fos信号通路的抑制作用,以及抗激素疗法的分子机制。抗激素常用于乳腺癌和前列腺癌治疗,分别通过抑制雌激素或雄激素受体来抑制癌症增殖。在此,我们全面概述了NHRs介导的基因抑制的各种机制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验